{"transactions":[{"id":1954291,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-15T01:32:33.000Z","date":"2023-03-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on March 11, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on March 11, 2023."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-23-018774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919123018774/doc4.xml","form_type":"4"}},{"id":1954290,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-03-15T01:32:33.000Z","date":"2023-03-11","kind":"tax_withholding","acquired":false,"shares":1060,"price":0.59,"value":625.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership."}],"balance_after":41982,"source":{"system":"sec-edgar","filing":"0001209191-23-018774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919123018774/doc4.xml","form_type":"4"}},{"id":1954289,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-03-15T01:32:33.000Z","date":"2023-03-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership."}],"balance_after":43042,"source":{"system":"sec-edgar","filing":"0001209191-23-018774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919123018774/doc4.xml","form_type":"4"}},{"id":2088049,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-12-14T02:22:13.000Z","date":"2022-12-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on December 11, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on December 11, 2022."}],"balance_after":3125,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-22-061094","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122061094/doc4.xml","form_type":"4"}},{"id":2088048,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-12-14T02:22:13.000Z","date":"2022-12-11","kind":"tax_withholding","acquired":false,"shares":1081,"price":0.59,"value":637.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership."}],"balance_after":39917,"source":{"system":"sec-edgar","filing":"0001209191-22-061094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122061094/doc4.xml","form_type":"4"}},{"id":2088047,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-12-14T02:22:13.000Z","date":"2022-12-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership."}],"balance_after":40998,"source":{"system":"sec-edgar","filing":"0001209191-22-061094","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122061094/doc4.xml","form_type":"4"}},{"id":2160245,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-09-13T23:53:21.000Z","date":"2022-09-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on September 11, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on September 11, 2022."}],"balance_after":6250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-22-049787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122049787/doc4.xml","form_type":"4"}},{"id":2160244,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-09-13T23:53:21.000Z","date":"2022-09-11","kind":"tax_withholding","acquired":false,"shares":1081,"price":0.5623,"value":607.8463,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":44503,"source":{"system":"sec-edgar","filing":"0001209191-22-049787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122049787/doc4.xml","form_type":"4"}},{"id":2160243,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-09-13T23:53:21.000Z","date":"2022-09-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":45584,"source":{"system":"sec-edgar","filing":"0001209191-22-049787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122049787/doc4.xml","form_type":"4"}},{"id":2232733,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-06-14T23:14:24.000Z","date":"2022-06-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on June 11, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on June 11, 2022."}],"balance_after":9375,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-22-036809","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122036809/doc4.xml","form_type":"4"}},{"id":2232732,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-06-14T23:14:24.000Z","date":"2022-06-11","kind":"tax_withholding","acquired":false,"shares":1081,"price":0.7702,"value":832.5862,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":42459,"source":{"system":"sec-edgar","filing":"0001209191-22-036809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122036809/doc4.xml","form_type":"4"}},{"id":2232731,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-06-14T23:14:24.000Z","date":"2022-06-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":43540,"source":{"system":"sec-edgar","filing":"0001209191-22-036809","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122036809/doc4.xml","form_type":"4"}},{"id":2333357,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2022-03-16T00:14:36.000Z","date":"2022-03-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on March 11, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on March 11, 2022."}],"balance_after":12500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-22-019000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122019000/doc4.xml","form_type":"4"}},{"id":2333356,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-03-16T00:14:36.000Z","date":"2022-03-11","kind":"tax_withholding","acquired":false,"shares":1281,"price":0.6923,"value":886.8363,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":40415,"source":{"system":"sec-edgar","filing":"0001209191-22-019000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122019000/doc4.xml","form_type":"4"}},{"id":2333355,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-03-16T00:14:36.000Z","date":"2022-03-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":41696,"source":{"system":"sec-edgar","filing":"0001209191-22-019000","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919122019000/doc4.xml","form_type":"4"}},{"id":2473571,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-12-15T00:17:59.000Z","date":"2021-12-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on December 11, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on December 11, 2021."}],"balance_after":15625,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-21-069617","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121069617/doc4.xml","form_type":"4"}},{"id":2473570,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-12-15T00:17:59.000Z","date":"2021-12-11","kind":"tax_withholding","acquired":false,"shares":1081,"price":0.635,"value":686.435,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":38571,"source":{"system":"sec-edgar","filing":"0001209191-21-069617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121069617/doc4.xml","form_type":"4"}},{"id":2473569,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-12-15T00:17:59.000Z","date":"2021-12-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":39652,"source":{"system":"sec-edgar","filing":"0001209191-21-069617","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121069617/doc4.xml","form_type":"4"}},{"id":2563110,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-09-22T01:14:28.000Z","date":"2021-09-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on September 11, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on September 11, 2021."}],"balance_after":18750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-21-057189","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121057189/doc4.xml","form_type":"4"}},{"id":2563109,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-09-22T01:14:28.000Z","date":"2021-09-11","kind":"tax_withholding","acquired":false,"shares":1081,"price":0.9975,"value":1078.2975,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":36527,"source":{"system":"sec-edgar","filing":"0001209191-21-057189","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121057189/doc4.xml","form_type":"4"}},{"id":2563108,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-09-22T01:14:28.000Z","date":"2021-09-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37608,"source":{"system":"sec-edgar","filing":"0001209191-21-057189","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121057189/doc4.xml","form_type":"4"}},{"id":2668431,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-06-16T01:12:01.000Z","date":"2021-06-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on June 11, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on June 11, 2021."}],"balance_after":21875,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-21-040796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121040796/doc4.xml","form_type":"4"}},{"id":2668430,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-06-16T01:12:01.000Z","date":"2021-06-11","kind":"tax_withholding","acquired":false,"shares":1081,"price":1.53,"value":1653.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":34483,"source":{"system":"sec-edgar","filing":"0001209191-21-040796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121040796/doc4.xml","form_type":"4"}},{"id":2668429,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-06-16T01:12:01.000Z","date":"2021-06-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35564,"source":{"system":"sec-edgar","filing":"0001209191-21-040796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121040796/doc4.xml","form_type":"4"}},{"id":2677728,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2021-06-08T23:20:15.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date."}],"balance_after":120000,"derivative":{"exercise_price":1.45,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-21-039033","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121039033/doc4.xml","form_type":"4"}},{"id":2789278,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2021-03-16T01:35:42.000Z","date":"2021-03-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on March 11, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on March 11, 2021."}],"balance_after":25000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-21-020633","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121020633/doc4.xml","form_type":"4"}},{"id":2789277,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-03-16T01:35:42.000Z","date":"2021-03-11","kind":"tax_withholding","acquired":false,"shares":1284,"price":2.03,"value":2606.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":32439,"source":{"system":"sec-edgar","filing":"0001209191-21-020633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121020633/doc4.xml","form_type":"4"}},{"id":2789276,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2021-03-16T01:35:42.000Z","date":"2021-03-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33723,"source":{"system":"sec-edgar","filing":"0001209191-21-020633","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919121020633/doc4.xml","form_type":"4"}},{"id":2944565,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-12-16T02:33:09.000Z","date":"2020-12-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on December 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on December 11, 2020."}],"balance_after":28125,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-20-063668","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120063668/doc4.xml","form_type":"4"}},{"id":2944564,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-12-16T02:33:09.000Z","date":"2020-12-11","kind":"tax_withholding","acquired":false,"shares":1081,"price":1.69,"value":1826.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":30598,"source":{"system":"sec-edgar","filing":"0001209191-20-063668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120063668/doc4.xml","form_type":"4"}},{"id":2944563,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-12-16T02:33:09.000Z","date":"2020-12-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31679,"source":{"system":"sec-edgar","filing":"0001209191-20-063668","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120063668/doc4.xml","form_type":"4"}},{"id":3031434,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-09-16T01:37:53.000Z","date":"2020-09-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on September 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on September 11, 2020."}],"balance_after":31250,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-20-050615","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120050615/doc4.xml","form_type":"4"}},{"id":3031433,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-09-16T01:37:53.000Z","date":"2020-09-11","kind":"tax_withholding","acquired":false,"shares":1081,"price":0.8095,"value":875.0695,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":28554,"source":{"system":"sec-edgar","filing":"0001209191-20-050615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120050615/doc4.xml","form_type":"4"}},{"id":3031432,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-09-16T01:37:53.000Z","date":"2020-09-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29635,"source":{"system":"sec-edgar","filing":"0001209191-20-050615","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120050615/doc4.xml","form_type":"4"}},{"id":3110621,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-06-16T01:29:14.000Z","date":"2020-06-11","kind":"exercise","acquired":false,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on June 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on June 11, 2020."}],"balance_after":34375,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001209191-20-036856","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120036856/doc4.xml","form_type":"4"}},{"id":3110620,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-06-16T01:29:14.000Z","date":"2020-06-11","kind":"tax_withholding","acquired":false,"shares":1081,"price":0.8001,"value":864.9081,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":26510,"source":{"system":"sec-edgar","filing":"0001209191-20-036856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120036856/doc4.xml","form_type":"4"}},{"id":3110619,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-06-16T01:29:14.000Z","date":"2020-06-11","kind":"exercise","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27591,"source":{"system":"sec-edgar","filing":"0001209191-20-036856","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120036856/doc4.xml","form_type":"4"}},{"id":3211283,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2020-03-14T01:43:16.000Z","date":"2020-03-11","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted Stock Units vested on March 11, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units vested on March 11, 2020."}],"balance_after":37500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001209191-20-019073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120019073/doc4.xml","form_type":"4"}},{"id":3211282,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-03-14T01:43:16.000Z","date":"2020-03-11","kind":"tax_withholding","acquired":false,"shares":5085,"price":0.8777,"value":4463.1045,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 12,500 Restricted Stock Units, the grant of which was previously reported on a Form 4."}],"balance_after":24446,"source":{"system":"sec-edgar","filing":"0001209191-20-019073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120019073/doc4.xml","form_type":"4"}},{"id":3211281,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-03-14T01:43:16.000Z","date":"2020-03-11","kind":"exercise","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29551,"source":{"system":"sec-edgar","filing":"0001209191-20-019073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919120019073/doc4.xml","form_type":"4"}},{"id":3597264,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-14T01:52:57.000Z","date":"2019-03-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Grant of restricted stock units under the AgeX 2017 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One quarter of the restricted stock units shall vest upon the completion of 12 months of continuous employment from the date of grant and the balance shall vest in twelve equal quarterly installments upon completion of each quarter of continuous service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"One quarter of the restricted stock units shall vest upon the completion of 12 months of continuous employment from the date of grant and the balance shall vest in twelve equal quarterly installments upon completion of each quarter of continuous service."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-19-019321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919119019321/doc4.xml","form_type":"4"}},{"id":3597263,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2019-03-14T01:52:57.000Z","date":"2019-03-11","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One quarter shall vest on March 11, 2020 and the remaining shall vest monthly over 36 months, based upon continuous service."}],"balance_after":100000,"derivative":{"exercise_price":4.28,"expiration_date":"2029-03-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-19-019321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919119019321/doc4.xml","form_type":"4"}},{"id":3734143,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock, $0.0001 par value","published_at":"2018-12-13T01:30:06.000Z","date":"2018-12-10","kind":"purchase","acquired":true,"shares":4000,"price":3.8607,"value":15442.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price of $3.8607 per share represents a weighted average of prices ranging from $3.8566 to $3.8634 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price."}],"balance_after":15460,"source":{"system":"sec-edgar","filing":"0001209191-18-062349","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1708599/000120919118062349/doc4.xml","form_type":"4"}},{"id":3812085,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-09-20T01:38:49.000Z","date":"2018-09-17","kind":"exercise","acquired":false,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on September 17, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on September 17, 2018."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":10938},"source":{"system":"sec-edgar","filing":"0001209191-18-051725","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118051725/doc4.xml","form_type":"4"}},{"id":3812084,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-09-20T01:38:49.000Z","date":"2018-09-17","kind":"tax_withholding","acquired":false,"shares":3783,"price":2.31,"value":8738.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 10,938 Restricted Stock Units, the grant of which was previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include shares that may be acquired upon the exercise of certain stock options."}],"balance_after":893913,"source":{"system":"sec-edgar","filing":"0001209191-18-051725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118051725/doc4.xml","form_type":"4"}},{"id":3812083,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-09-20T01:38:49.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":10938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include shares that may be acquired upon the exercise of certain stock options."}],"balance_after":897696,"source":{"system":"sec-edgar","filing":"0001209191-18-051725","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118051725/doc4.xml","form_type":"4"}},{"id":3868953,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-07-12T23:50:19.000Z","date":"2018-07-10","kind":"exercise","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on July 10, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on July 10, 2018."}],"balance_after":10938,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001209191-18-042495","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118042495/doc4.xml","form_type":"4"}},{"id":3868952,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-07-12T23:50:19.000Z","date":"2018-07-10","kind":"tax_withholding","acquired":false,"shares":541,"price":2.2,"value":1190.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,562 Restricted Stock Units, the grant of which was previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 10,938 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":886758,"source":{"system":"sec-edgar","filing":"0001209191-18-042495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118042495/doc4.xml","form_type":"4"}},{"id":3868951,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-07-12T23:50:19.000Z","date":"2018-07-10","kind":"exercise","acquired":true,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 10,938 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":887299,"source":{"system":"sec-edgar","filing":"0001209191-18-042495","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118042495/doc4.xml","form_type":"4"}},{"id":3965020,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-04-13T01:00:07.000Z","date":"2018-04-10","kind":"exercise","acquired":false,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on April 10, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on April 10, 2018."}],"balance_after":12500,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001209191-18-024791","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118024791/doc4.xml","form_type":"4"}},{"id":3965019,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-04-13T01:00:07.000Z","date":"2018-04-10","kind":"tax_withholding","acquired":false,"shares":541,"price":2.49,"value":1347.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,563 Restricted Stock Units, the grant of which was previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 12,500 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":885737,"source":{"system":"sec-edgar","filing":"0001209191-18-024791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118024791/doc4.xml","form_type":"4"}},{"id":3965018,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-04-13T01:00:07.000Z","date":"2018-04-10","kind":"exercise","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 12,500 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":886278,"source":{"system":"sec-edgar","filing":"0001209191-18-024791","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118024791/doc4.xml","form_type":"4"}},{"id":4100934,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-01-13T01:30:08.000Z","date":"2018-01-10","kind":"exercise","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on January 10, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on January 10, 2018."}],"balance_after":14063,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001209191-18-003488","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118003488/doc4.xml","form_type":"4"}},{"id":4100933,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-01-13T01:30:08.000Z","date":"2018-01-10","kind":"tax_withholding","acquired":false,"shares":686,"price":2.68,"value":1838.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,562 Restricted Stock Units, the grant of which was previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 14,063 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":884715,"source":{"system":"sec-edgar","filing":"0001209191-18-003488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118003488/doc4.xml","form_type":"4"}},{"id":4100932,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-01-13T01:30:08.000Z","date":"2018-01-10","kind":"exercise","acquired":true,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 14,063 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":885401,"source":{"system":"sec-edgar","filing":"0001209191-18-003488","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118003488/doc4.xml","form_type":"4"}},{"id":4187643,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-10-12T23:35:56.000Z","date":"2017-10-10","kind":"exercise","acquired":false,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on October 10, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on October 10, 2017."}],"balance_after":15625,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":1563},"source":{"system":"sec-edgar","filing":"0001209191-17-056779","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117056779/doc4.xml","form_type":"4"}},{"id":4187642,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-10-12T23:35:56.000Z","date":"2017-10-10","kind":"tax_withholding","acquired":false,"shares":588,"price":2.81,"value":1652.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,563 Restricted Stock Units, the grant of which was previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 15,625 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":883839,"source":{"system":"sec-edgar","filing":"0001209191-17-056779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117056779/doc4.xml","form_type":"4"}},{"id":4187641,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-10-12T23:35:56.000Z","date":"2017-10-10","kind":"exercise","acquired":true,"shares":1563,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 15,625 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":884427,"source":{"system":"sec-edgar","filing":"0001209191-17-056779","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117056779/doc4.xml","form_type":"4"}},{"id":4226964,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-08-23T23:23:31.000Z","date":"2017-08-22","kind":"purchase","acquired":true,"shares":2000,"price":2.599,"value":5198.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":882864,"source":{"system":"sec-edgar","filing":"0001209191-17-050016","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117050016/doc4.xml","form_type":"4"}},{"id":4258687,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-07-12T23:21:59.000Z","date":"2017-07-10","kind":"exercise","acquired":false,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on July 10, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on July 10, 2017."}],"balance_after":17188,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":1562},"source":{"system":"sec-edgar","filing":"0001209191-17-044959","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117044959/doc4.xml","form_type":"4"}},{"id":4258686,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-07-12T23:21:59.000Z","date":"2017-07-10","kind":"tax_withholding","acquired":false,"shares":587,"price":3.09,"value":1813.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 1,562 Restricted Stock Units, the grant of which was previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 17,188 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":880864,"source":{"system":"sec-edgar","filing":"0001209191-17-044959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117044959/doc4.xml","form_type":"4"}},{"id":4258685,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-07-12T23:21:59.000Z","date":"2017-07-10","kind":"exercise","acquired":true,"shares":1562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 17,188 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":881451,"source":{"system":"sec-edgar","filing":"0001209191-17-044959","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117044959/doc4.xml","form_type":"4"}},{"id":4340914,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-05-02T00:58:49.000Z","date":"2017-04-10","kind":"exercise","acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on April 10, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on April 10, 2017."}],"balance_after":18750,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0001209191-17-029046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117029046/doc4.xml","form_type":"4"}},{"id":4340913,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-05-02T00:58:49.000Z","date":"2017-04-10","kind":"tax_withholding","acquired":false,"shares":2348,"price":3.33,"value":7818.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 6,250 Restricted Stock Units, the grant of which was previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 18,750 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":879889,"source":{"system":"sec-edgar","filing":"0001209191-17-029046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117029046/doc4.xml","form_type":"4"}},{"id":4340912,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":115572,"kind":"person","name":"WEST MICHAEL D","position":1,"cik":"0001202529","reported_name":"WEST MICHAEL D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-05-02T00:58:49.000Z","date":"2017-04-10","kind":"exercise","acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 18,750 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":882237,"source":{"system":"sec-edgar","filing":"0001209191-17-029046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117029046/doc4.xml","form_type":"4"}}]}